341 related articles for article (PubMed ID: 36230692)
1. Potassium Ion Channels in Malignant Central Nervous System Cancers.
Boyle Y; Johns TG; Fletcher EV
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230692
[TBL] [Abstract][Full Text] [Related]
2. Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
Dewdney B; Ursich L; Fletcher EV; Johns TG
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497413
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
4. Ion Channels as Therapeutic Targets in High Grade Gliomas.
Griffin M; Khan R; Basu S; Smith S
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33096667
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
6. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
7. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
[TBL] [Abstract][Full Text] [Related]
8. Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
Zhang X; Zhang W; Mao XG; Cao WD; Zhen HN; Hu SJ
Curr Cancer Drug Targets; 2019; 19(2):101-108. PubMed ID: 29848277
[TBL] [Abstract][Full Text] [Related]
9. Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives.
Lefranc F
Front Cell Dev Biol; 2021; 9():618961. PubMed ID: 34458247
[TBL] [Abstract][Full Text] [Related]
10. Potassium Ion Channels in Glioma: From Basic Knowledge into Therapeutic Applications.
Younes S; Mourad N; Salla M; Rahal M; Hammoudi Halat D
Membranes (Basel); 2023 Apr; 13(4):. PubMed ID: 37103862
[TBL] [Abstract][Full Text] [Related]
11. Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours.
Nguyen TYT; Cacciottola L; Camboni A; Ravau J; De Vos M; Demeestere I; Donnez J; Dolmans MM
Hum Reprod; 2021 Apr; 36(5):1296-1309. PubMed ID: 33394011
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology series of brain-related disorders in Mongolia: nationwide registry-based epidemiological study on CNS tumours in Mongolia, 2015-2019.
Sandagdorj T; Tudev U; Jamiyandorj O; Oka T; Lkhagvasuren B
J Integr Neurosci; 2022 Jan; 21(1):24. PubMed ID: 35164460
[TBL] [Abstract][Full Text] [Related]
13. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
14. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
15. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
Desland FA; Hormigo A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027976
[TBL] [Abstract][Full Text] [Related]
16. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
[TBL] [Abstract][Full Text] [Related]
17. Institutional experience of paediatric high-grade central nervous system tumours: an analysis of 74 patients and review of the literature.
Pinarli FG; Oguz A; Karadeniz C; Okur A; Sarac A; Baykaner K; Bora H; Poyraz A
Contemp Oncol (Pozn); 2012; 16(1):26-33. PubMed ID: 23788851
[TBL] [Abstract][Full Text] [Related]
18. Ion Channels in Glioma Malignancy.
Catacuzzeno L; Sforna L; Esposito V; Limatola C; Franciolini F
Rev Physiol Biochem Pharmacol; 2021; 181():223-267. PubMed ID: 32930879
[TBL] [Abstract][Full Text] [Related]
19. Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems.
Cao H; Li X; Wang F; Zhang Y; Xiong Y; Yang Q
Curr Med Chem; 2020; 27(4):599-629. PubMed ID: 31400262
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria.
Gandhi L; Ou SI; Shaw AT; Barlesi F; Dingemans AC; Kim DW; Camidge DR; Hughes BGM; Yang JC; de Castro J; Crino L; Léna H; Do P; Golding S; Bordogna W; Zeaiter A; Kotb A; Gadgeel S
Eur J Cancer; 2017 Sep; 82():27-33. PubMed ID: 28646771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
